ConductScience.org, home

Paper41209563

Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy.

Feng W and 7 others. Int J Med Sci, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy. Papers, record 41209563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41209563

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy.
PubMed
Journal
Int J Med Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-11-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feng WWanqi
2Zhao YYifan
3Yu DDongran
4Jia WWenyu
5Cao HHui
6Zhang YYuling
7Cao JJie
8Li ZZequn

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cancer VaccinesMajor topic
NeoplasmsMajor topic
Antigens, NeoplasmMajor topic
ImmunotherapyMajor topic
Humans
Immune Checkpoint Inhibitors
Combined Modality Therapy
Precision Medicine
Animals

Source PubMed

Download CSV of topics

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134676374Targeting public neoantigens for cancer immunotherapy.Nat Cancer2021https://conductscience.org/library/papers/34676374PubMed
238713894Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.Blood Adv2024https://conductscience.org/library/papers/38713894PubMed
336851159Improved DNA Vaccine Delivery with Needle-Free Injection Systems.Vaccines (Basel)2023https://conductscience.org/library/papers/36851159PubMed
429326426mRNA vaccines - a new era in vaccinology.Nat Rev Drug Discov2018https://conductscience.org/library/papers/29326426PubMed
538195752Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.Nat Med2024https://conductscience.org/library/papers/38195752PubMed
635359994T Cell Metabolism in Infection.Front Immunol2022https://conductscience.org/library/papers/35359994PubMed
739270889Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?Int J Biol Macromol2024https://conductscience.org/library/papers/39270889PubMed
829889594Cytokines in the Treatment of Cancer.J Interferon Cytokine Res2019https://conductscience.org/library/papers/29889594PubMed
927793569Dendritic Cells and Cancer Immunity.Trends Immunol2016https://conductscience.org/library/papers/27793569PubMed
1037872225CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.Nat Med2023https://conductscience.org/library/papers/37872225PubMed
1140938661Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40938661PubMed
1233603370Application of Radiosensitizers in Cancer Radiotherapy.Int J Nanomedicine2021https://conductscience.org/library/papers/33603370PubMed
1339244900A recent perspective on designing tumor vaccines for tumor immunology.Int Immunopharmacol2024https://conductscience.org/library/papers/39244900PubMed
1438086815Therapeutic cancer vaccines: advancements, challenges, and prospects.Signal Transduct Target Ther2023https://conductscience.org/library/papers/38086815PubMed
1537254712Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37254712PubMed
1636612133Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies.Cancers (Basel)2022https://conductscience.org/library/papers/36612133PubMed
1737897003In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future.Vaccines (Basel)2023https://conductscience.org/library/papers/37897003PubMed
1833826117A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.J Med Toxicol2021https://conductscience.org/library/papers/33826117PubMed
1937029123Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37029123PubMed
2022437871Cancer immunotherapy via dendritic cells.Nat Rev Cancer2012https://conductscience.org/library/papers/22437871PubMed

See all 88 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42583501Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction.Front Genet2026https://conductscience.org/library/papers/42583501PubMed
42220542Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings.Front Immunol2026https://conductscience.org/library/papers/42220542PubMed
41754822Integrative Spatial Transcriptomics and Immunoinformatics for Prognostic Multi-Epitope Vaccine Construct Prediction Against Synovial Sarcoma.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41754822PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41209563

GET https://conductscience.org/api/papers/v1/41209563/references?page=2